Latest news
Theriva Biologics Doses First Patient in VIRAGE2 Trial of VCN-01 for Metastatic Pancreatic Cancer - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:44:00 GMTMetaVia’s DA-1726 Reaches Highest Doses in Phase 1 Study Ahead of 2026 Results - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:39:00 GMTVivani Medical Completes Dosing in Phase 1 Trial of Semaglutide Implant - The Clinical Trial VanguardThe Clinical Trial Vanguard · Fri, 07 Aug 2026 06:39:00 GMTThe mRNA technology behind Moderna’s Covid vaccine reaches the flu - The GuardianThe Guardian · Thu, 06 Aug 2026 14:09:00 GMT